Khorana et al. [140] reported that vascular endothelial growth factor (VEGF)-expressing TAM increases median survival in patients with colon carcinoma, and a decreased number of macrophages is associated with more advanced stages among CRC patients. The gene discussed is VEGFA; the disease is colorectal carcinoma.